By Norma Erickson, President Medical consumers worldwide applaud the recent FDA decision not to expand the use of Gardasil to women over the age of 26. Now they want to know when the FDA will admit the original approval may have been a mistake. FOR IMMEDIATE RELEASE PRLog (Press Release) – Apr 12, 2011 – […]
Behind the Scenes: The Evolution of an HPV Industry
By Norma Erickson, President of SaneVax Inc. April 5, 2011 The first papillomavirus was discovered in the 1930’s by Dr. Richard E. Shope. It was the cottontail rabbit papillomavirus, or the Shope papillomavirus, which occurred in warts that frequently developed into cancerous tumors1. Dr. Shope was able to isolate the virus, inject it into […]
HPV Genotyping Clinical Guidelines?
SANE Vax, Inc. By Norma Erickson March 27, 2011 HPV Genotyping Clinical Update National Cancer Institute studies have shown that women with HPV types 16 and 18 have about a 20% risk of progressing to CIN3 over 10 years despite negative Pap tests, and colposcopy may be useful for these women. However, most HPV […]
HPV Vaccines: What exactly are they effective against?
Since HPV vaccines have not been proven to prevent cancer, the CDC lists three alternate ways to judge the vaccines’ efficacy. None of them work. Where does that leave medical consumers? FOR IMMEDIATE RELEASE PRLog (Press Release) – Mar 19, 2011 – According to the prescribing information packet, GARDASIL is a vaccine indicated in girls […]
Cervical Cancer vs Prostate Cancer: Is the FDA practicing sexual discrimination?
FDA advisory panels reject the use of two separate prostate cancer prevention measures yet approve cervical cancer preventive shots using virtually the same criteria. What is wrong with this picture? FOR IMMEDIATE RELEASE PRLog (Press Release) – Mar 01, 2011 – November 2010, an FDA advisory panel soundly rejected the proposed use of two drugs, […]
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 40
- Next Page »
